Efficacy of Electronic Cigarettes Noninferior to Varenicline
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- For smokers who are motivated to quit, the quit rate is noninferior for electronic cigarettes (ECs) versus varenicline and is higher for ECs than nicotine replacement therapy (NRT) in the form of nicotine gum, according to a study published online Jan. 29 in JAMA Internal Medicine.
Hao-Xing Lin, Dr.P.H., from Peking University in Beijing, and colleagues conducted a randomized clinical trial at seven sites involving participants who were smoking at least 10 cigarettes per day and were motivated to quit. A cartridge-based EC, varenicline, and 2 or 4 mg nicotine chewing gum were provided for 12 weeks and accompanied by minimal behavioral support. Sustained abstinence from smoking at six months was the primary outcome. A total of 1,068 participants were included and randomly assigned to the EC, varenicline, and NRT arms (409, 409, and 250, respectively).
The researchers found that in the EC, varenicline, and NRT arms, the six-month biochemically validated abstinence rates were 15.7, 14.2, and 8.8 percent, respectively. The quit rate was noninferior in the EC versus the varenicline arm (absolute risk reduction, 1.47 percent; 95 percent confidence interval, −1.41 to 4.34 percent) and was higher in the EC versus the NRT arm (odds ratio, 1.92; 95 percent confidence interval, 1.15 to 3.21). During the initial three months, treatment adherence was similar in all study arms; 62.8 percent of participants in the EC arm were still using ECs at six months, while in the other arms, interventions were no longer used.
"As 63 percent of participants in the EC arm still used their products at six months, further studies are needed to assess whether such use is beneficial or harmful," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Upping Dose May Aid Smoking Cessation After Initial Treatment Failure
TUESDAY, May 7, 2024 -- A dosage increase may provide longer-term benefit for smokers receiving varenicline or combination nicotine replacement therapy who are nonabstinent after...
Quantitative Interstitial Abnormality Linked to Severe ARD in Smokers
MONDAY, May 6, 2024 -- For individuals with a smoking history, quantitative interstitial abnormality (QIA) progression is associated with increased odds of severe acute...
About 56 Percent of Pregnant Smokers Quit During Pregnancy
THURSDAY, May 2, 2024 -- More than half of women who smoke before pregnancy quit while pregnant, according to research published in the May 2 issue of the U.S. Centers for Disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.